The Power of Personalized Quantitative Imaging
LDA+ assists the diagnosis and assessment of COVID-19 or pneumonia severity, and potential co-existing emphysema via quantification of low and high-density regions in chest CT images. Studies show that quantification is important for triage and managing risk of adverse events in COVID-192.
For Your Practice
LDA+ is a fully automated solution delivering quantitative analysis and 3D visualization to the patient study in PACS. LDA+ is now available in multiple regions of the world and is ready for immediate deployment through Imbio or our partners for ease of implementation.
Suggested use cases for LDA+
- COVID-19 patient diagnoses, triage, and potential follow-up
- General pneumonia diagnosis and follow-up
1- Lucas G. Sapienza, Karim Nasra, Vinícius F. Calsavara, Tania B. Little, Vrinda Narayana, Eyad Abu-Isa, Risk of in-hospital death associated with Covid-19 lung consolidations on chest computed tomography – A novel translational approach using a radiation oncology contour software, European Journal of Radiology Open, Volume 8, 2021, 100322, ISSN 2352-0477, https://doi.org/10.1016/j.ejro.2021.100322.
2 – Davide Colombi, Flavio C. Bodini, Marcello Petrini, Gabriele Maffi, Nicola Morelli, Gianluca Milanese, Mario Silva, Nicola Sverzellati, and Emanuele Michieletti “Well-Aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.” Radiology, April 17, 2020, 201433. https://doi.org/10.1148/radiol.2020201433.